Pharmacotherapy (Record no. 1505)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 08927nam a2200481 a 4500 |
| 001 - CONTROL NUMBER | |
| control field | scn00350028 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20210413150551.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
| fixed length control field | m||||||||||||||||| |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr||n||||||||n |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 161024s2014||||nyu|||||s|||||||||||eng|| |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER | |
| LC control number | 2013038907 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 0071800530 (printISBN) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 0071800549 (e-ISBN) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9780071800532 (print-ISBN) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9780071800549 (e-ISBN) |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)859253298 |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RM263 |
| Item number | .P56 2014 |
| 060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER | |
| Classification number | WB 330 |
| Item number | P5357 2014 |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 615.5/8 |
| Edition number | 23 |
| 130 0# - MAIN ENTRY--UNIFORM TITLE | |
| Uniform title | Pharmacotherapy (New York) |
| 245 10 - TITLE STATEMENT | |
| Title | Pharmacotherapy |
| Medium | [electronic resource] : |
| Remainder of title | a pathophysiologic approach / |
| Statement of responsibility, etc. | [edited by] Joseph T. DiPiro, Robert L. Talbert, Gary C. Yee, Gary R. Matzke, Barbara G. Wells, L. Michael Posey. |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 9th ed. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Place of publication, distribution, etc. | New York, N.Y. : |
| Name of publisher, distributor, etc. | McGraw-Hill Education LLC., |
| Date of publication, distribution, etc. | c2014. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | xxxviii, 2586 p. : |
| Other physical details | ill., figs., tables. |
| 490 1# - SERIES STATEMENT | |
| Series statement | McGraw-Hill's AccessPharmacy |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE | |
| Bibliography, etc | Includes bibliographical references and indexes. |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | eChapters -- eCHAPTER 1. Health Literacy and Medication Use -- eCHAPTER 2. Cultural Competency -- eCHAPTER 3. Principles and Practices of Medication Safety -- eCHAPTER 4. Evidence-Based Medicine -- eCHAPTER 5. Clinical Pharmacokinetics and Pharmacodynamics -- eCHAPTER 6. Pharmacogenetics -- eCHAPTER 7. Pediatrics -- eCHAPTER 8. Geriatrics -- eCHAPTER 9. Palliative Care -- eCHAPTER 10. Clinical Toxicology -- eCHAPTER 11. Emergency Preparedness and Response: Biologic Exposures -- eCHAPTER 12. Emergency Preparedness: Identification and Management of Chemical and Radiologic Exposures -- eCHAPTER 13. Cardiovascular Testing -- eCHAPTER 14. Introduction to Pulmonary Function Testing -- eCHAPTER 15. Drug-Induced Pulmonary Diseases -- eCHAPTER 16. Evaluation of the Gastrointestinal Tract -- eCHAPTER 17. Drug-Induced Liver Disease -- eCHAPTER 18. Evaluation of Kidney Function -- eCHAPTER 19. Evaluation of Neurologic Illness -- eCHAPTER 20. Evaluation of Psychiatric Disorders -- eCHAPTER 21. Function and Evaluation of the Immune System -- eCHAPTER 22. Allergic and Pseudoallergic Drug Reactions -- eCHAPTER 23. Dermatologic Drug Reactions and Common Skin Conditions -- eCHAPTER 24. Drug-Induced Hematologic Disorders -- eCHAPTER 25. Laboratory Tests to Direct Antimicrobial Pharmacotherapy --Section 1. Cardiovascular Disorders -- CHAPTER 1. Cardiovascular Testing -- CHAPTER 2. Cardiac Arrest -- CHAPTER 3. Hypertension -- CHAPTER 4. Chronic Heart Failure -- CHAPTER 5. Acute Decompensated Heart Failure -- CHAPTER 6. Ischemic Heart Disease -- CHAPTER 7. Acute Coronary Syndromes -- CHAPTER 8. The Arrhythmias -- CHAPTER 9. Venous Thromboembolism -- CHAPTER 10. Stroke -- CHAPTER 11. Hyperlipidemia -- CHAPTER 12. Peripheral Arterial Disease -- CHAPTER 13. Use of Vasopressors and Inotropes in the Pharmacotherapy of Shock -- CHAPTER 14. Hypovolemic Shock --Section 2. Respiratory Disorders -- CHAPTER 15. Asthma -- CHAPTER 16. Chronic Obstructive Pulmonary Disease -- CHAPTER 17. Pulmonary Arterial Hypertension -- CHAPTER 18. Cystic Fibrosis --Section 3. Gastrointestinal Disorders -- CHAPTER 19. Gastroesophageal Reflux Disease -- CHAPTER 20. Peptic Ulcer Disease -- CHAPTER 21. Inflammatory Bowel Disease -- CHAPTER 22. Nausea and Vomiting -- CHAPTER 23. Diarrhea, Constipation, and Irritable Bowel Syndrome -- CHAPTER 24. Portal Hypertension and Cirrhosis -- CHAPTER 25. Pancreatitis -- CHAPTER 26. Viral Hepatitis -- CHAPTER 27. Celiac Disease --Section 4. Renal Disorders -- CHAPTER 28. Acute Kidney Injury -- CHAPTER 29. Chronic Kidney Disease -- CHAPTER 30. Hemodialysis and Peritoneal Dialysis -- CHAPTER 31. Drug-Induced Kidney Disease -- CHAPTER 32. Glomerulonephritis -- CHAPTER 33. Drug Therapy Individualization for Patients with Chronic Kidney Disease -- CHAPTER 34. Disorders of Sodium and Water Homeostasis -- CHAPTER 35. Disorders of Calcium and Phosphorus Homeostasis -- CHAPTER 36. Disorders of Potassium and Magnesium Homeostasis -- CHAPTER 37. Acid–Base Disorders --Section 5. Neurologic Disorders -- CHAPTER 38. Alzheimer"s Disease -- CHAPTER 39. Multiple Sclerosis -- CHAPTER 40. Epilepsy -- CHAPTER 41. Status Epilepticus -- CHAPTER 42. Acute Management of the Brain Injury Patient -- CHAPTER 43. Parkinson"s Disease -- CHAPTER 44. Pain Management -- CHAPTER 45. Headache Disorders --Section 6. Psychiatric Disorders -- CHAPTER 46. Attention Deficit/Hyperactivity Disorder -- CHAPTER 47. Eating Disorders -- CHAPTER 48. Substance-Related Disorders I: Overview and Depressants, Stimulants, and Hallucinogens -- CHAPTER 49. Substance-Related Disorders II: Alcohol, Nicotine, and Caffeine. |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | CHAPTER 50. Schizophrenia -- CHAPTER 51. Major Depressive Disorder -- CHAPTER 52. Bipolar Disorder -- CHAPTER 53. Anxiety Disorders I: Generalized Anxiety, Panic, and Social Anxiety Disorders -- CHAPTER 54. Anxiety Disorders II: Posttraumatic Stress Disorder and Obsessive-Compulsive Disorder -- CHAPTER 55. Sleep Disorders -- CHAPTER 56. Disorders Associated with Intellectual Disabilities --Section 7. Endocrinologic Disorders -- CHAPTER 57. Diabetes Mellitus -- CHAPTER 58. Thyroid Disorders -- CHAPTER 59. Adrenal Gland Disorders -- CHAPTER 60. Pituitary Gland Disorders --Section 8. Gynecologic and Obstetric Disorders -- CHAPTER 61. Pregnancy and Lactation: Therapeutic Considerations -- CHAPTER 62. Contraception -- CHAPTER 63. Menstruation-Related Disorders -- CHAPTER 64. Endometriosis -- CHAPTER 65. Hormone Therapy in Women --Section 9. Urologic Disorders -- CHAPTER 66. Erectile Dysfunction -- CHAPTER 67. Benign Prostatic Hyperplasia -- CHAPTER 68. Urinary Incontinence --Section 10. Immunologic Disorders -- CHAPTER 69. Systemic Lupus Erythematosus -- CHAPTER 70. Solid-Organ Transplantation --Section 11. Rheumatologic Disorders -- CHAPTER 71. Osteoarthritis -- CHAPTER 72. Rheumatoid Arthritis -- CHAPTER 73. Osteoporosis and Other Metabolic Bone Diseases -- CHAPTER 74. Gout and Hyperuricemia --Section 12. Ophthalmic and Otolaryngological Disorders -- CHAPTER 75. Glaucoma -- CHAPTER 76. Allergic Rhinitis --Section 13. Dermatologic Disorders -- CHAPTER 77. Acne Vulgaris -- CHAPTER 78. Psoriasis -- CHAPTER 79. Atopic Dermatitis --Section 14. Hematologic Disorders -- CHAPTER 80. Anemias -- CHAPTER 81. Coagulation Disorders -- CHAPTER 82. Sickle Cell Disease --Section 15. Infectious Diseases -- CHAPTER 83. Antimicrobial Regimen Selection -- CHAPTER 84. Central Nervous System Infections -- CHAPTER 85. Lower Respiratory Tract Infections -- CHAPTER 86. Upper Respiratory Tract Infections -- CHAPTER 87. Influenza -- CHAPTER 88. Skin and Soft-Tissue Infections -- CHAPTER 89. Infective Endocarditis -- CHAPTER 90. Tuberculosis -- CHAPTER 91. Gastrointestinal Infections and Enterotoxigenic Poisonings -- CHAPTER 92. Intraabdominal Infections -- CHAPTER 93. Parasitic Diseases -- CHAPTER 94. Urinary Tract Infections and Prostatitis -- CHAPTER 95. Sexually Transmitted Diseases -- CHAPTER 96. Bone and Joint Infections -- CHAPTER 97. Severe Sepsis and Septic Shock -- CHAPTER 98. Superficial Fungal Infections -- CHAPTER 99. Invasive Fungal Infections -- CHAPTER 100. Infections in Immunocompromised Patients -- CHAPTER 101. Antimicrobial Prophylaxis in Surgery -- CHAPTER 102. Vaccines, Toxoids, and Other Immunobiologics -- CHAPTER 103. Human Immunodeficiency Virus Infection --Section 16. Oncologic Disorders -- CHAPTER 104. Cancer Treatment and Chemotherapy -- CHAPTER 105. Breast Cancer -- CHAPTER 106. Lung Cancer -- CHAPTER 107. Colorectal Cancer -- CHAPTER 108. Prostate Cancer -- CHAPTER 109. Lymphomas -- CHAPTER 110. Ovarian Cancer -- CHAPTER 111. Acute Leukemias -- CHAPTER 112. Chronic Leukemias -- CHAPTER 113. Multiple Myeloma -- CHAPTER 114. Myelodysplastic Syndromes -- CHAPTER 115. Renal Cell Carcinoma -- CHAPTER 116. Melanoma -- CHAPTER 117. Hematopoietic Stem Cell Transplantation --Section 17. Nutritional Disorders -- CHAPTER 118. Assessment of Nutrition Status and Nutrition Requirements -- CHAPTER 119. Parenteral Nutrition -- CHAPTER 120. Enteral Nutrition -- CHAPTER 121. Obesity. |
| 530 ## - ADDITIONAL PHYSICAL FORM AVAILABLE NOTE | |
| Additional physical form available note | Also issued in online and PDF version. |
| 588 ## - SOURCE OF DESCRIPTION NOTE | |
| Source of description note | Description based on cover image and table of contents, viewed on Oct. 24, 2016. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Chemotherapy. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Physiology, Pathological. |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Drug Therapy. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | DiPiro, Joseph T., |
| Relator term | ed. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Matzke, Gary R., |
| Relator term | ed. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Posey, L. Michael, |
| Relator term | ed. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Talbert, Robert L., |
| Relator term | ed. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Wells, Barbara G., |
| Relator term | ed. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Yee, Gary C., |
| Relator term | ed. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Online version: |
| Title | Pharmacotherapy, a pathophysiologic approach. |
| Edition | Ninth edition. |
| Place, publisher, and date of publication | New York, N.Y. : McGraw-Hill Education LLC., |
| Qualifying information | 2014. |
| International Standard Book Number | 9780071800549. |
| Record control number | (OCoLC)859253298 |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
| Uniform title | McGraw-Hill's AccessPharmacy. |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="http://accesspharmacy.mhmedical.com/book.aspx?bookid=689">http://accesspharmacy.mhmedical.com/book.aspx?bookid=689</a> |
No items available.